307 related articles for article (PubMed ID: 19438819)
1. Safety and efficacy of desloratadine in chronic idiopathic urticaria in clinical practice: an observational study of 9246 patients.
Augustin M; Ehrle S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):292-9. PubMed ID: 19438819
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of desloratadine in subjects with seasonal allergic rhinitis or chronic urticaria: results of four postmarketing surveillance studies.
Bachert C; Maurer M
Clin Drug Investig; 2010; 30(2):109-22. PubMed ID: 20067329
[TBL] [Abstract][Full Text] [Related]
3. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
DuBuske L
Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
Ortonne JP; Grob JJ; Auquier P; Dreyfus I
Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
[TBL] [Abstract][Full Text] [Related]
5. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
6. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients.
Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY
Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988
[TBL] [Abstract][Full Text] [Related]
8. [Desloratadine for chronic idiopathic urticaria].
Rottem M; Elbirt D; Sthoeger Z;
Harefuah; 2005 Aug; 144(8):547-53, 599, 598. PubMed ID: 16146151
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
[TBL] [Abstract][Full Text] [Related]
10. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes.
Grob JJ; Lachapelle JM
Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988
[TBL] [Abstract][Full Text] [Related]
11. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Ring J; Hein R; Gauger A; Bronsky E; Miller B
Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
[TBL] [Abstract][Full Text] [Related]
12. Safety of desloratadine syrup in children.
Bloom M; Staudinger H; Herron J
Curr Med Res Opin; 2004 Dec; 20(12):1959-65. PubMed ID: 15701213
[TBL] [Abstract][Full Text] [Related]
13. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
Bachert C
Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
[TBL] [Abstract][Full Text] [Related]
14. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity.
Kiyici S; Gul OO; Baskan EB; Hacioglu S; Budak F; Erturk E; Imamoglu S
Clin Exp Dermatol; 2010 Aug; 35(6):603-7. PubMed ID: 19874329
[TBL] [Abstract][Full Text] [Related]
15. Influence of desloratadine on oxidative stress markers in patients with chronic idiopathic urticaria.
Cassano N; Raho G; Filieri M; D'Argento V; Amoruso A; Filotico R; Vena GA
Int J Dermatol; 2006 Apr; 45(4):394-6. PubMed ID: 16650165
[TBL] [Abstract][Full Text] [Related]
16. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Monroe E; Finn A; Patel P; Guerrero R; Ratner P; Bernstein D;
J Am Acad Dermatol; 2003 Apr; 48(4):535-41. PubMed ID: 12664016
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria.
Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK
J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
20. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
